Cohen's SAC Capital Cuts Stake in Barrier Therapeutics (BTRX) to 1.21%
Tweet Send to a Friend
In a 13D filed after the close on Barrier Therapeutics (Nasdaq: BTRX), Steven Cohen's SAC Capital lowered its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
